Palabras clave
Rendimiento físico
Velocidad de la marcha
Adultos
Cómo citar
Copyright © | Todos los derechos reservados.
La revista posee los derechos de autor exclusivos para la publicación de este artículo en los términos de la ley brasileña 9610/98.
Reproducción parcial
El uso de partes de los textos, figuras y cuestionario del artículo es libre, siendo obligatoria la citación de los autores y revista.
Reproducción total
Está expresamente prohibido y debe ser autorizado por la revista.
Resumen
Objetivo: Evaluar y diagnosticar sarcopenia secundaria en pacientes adultos hospitalizados. Métodos: Se trata de un estudio transversal, realizado con 40 individuos, de ambos sexos, con edades comprendidas entre 18 y 60 años. Este estudio fue aprobado por el Comité de Ética en Investigación y los pacientes fueron investigados utilizando los métodos de diagnóstico de sarcopenia sugeridos por el European Working Group on Sarcopenia in Older People (EWGSOP-2), mediante el uso del cuestionario SARC-F, Five-Time Sit-Stand Test, medición de Circunferencia de Pantorrilla y Test de Velocidad de Marcha de 4 metros para clasificar la sarcopenia, además de una entrevista para obtener datos sociodemográficos y clínicos. Resultados: La edad promedio de los participantes fue de 44,65 años, la mayoría fueron del sexo femenino (75%), las mayores frecuencias en la muestra fueron enfermedad hepática, enfermedad pulmonar y enfermedad renal, donde el 25% eran Probable Sarcopénica (SP), el 15% eran identificados como sarcopénicos y el 10% de estos tenían sarcopenia severa. Conclusión: Este estudio identificó sarcopenia en adultos hospitalizados con antecedentes de caídas, cuya relevancia radica en señalar al equipo los cuidados necesarios para intervenir y prevenir lesiones por hospitalización prolongada.
Referencias
ABREU DCC de, et al. Prediction of Reduced Gait Speed Using 5-Time Sit-to-Stand Test in Healthy Older Adults. Journal of the American Medical Directors Association, 2022; 23(5):889-892.
BOHANNON RW e WANG YC. Four-meter Gait Speed: Normative Values and Reliability Determined for Adults Participating in the NIH Toolbox Study. Archives of Physical Medicine and Rehabilitation, 2019; 100(3):509-513.
BORDA MG, et al. Sarcopenia, lung disease and mortality: a secondary analysis of the CRELES study. Geriatr Gerontol Aging, 2019; 13(1):36-8.
BROUESSARD C, et al. Impact of Severe Sarcopenia on Rehospitalization and Survival One Year After a TAVR Procedure in Patients Aged 75 and Older. Clin Interv Aging, 2021; 16: 1285–1292.
CABANAS-VALDÉS R, et al. Assessment of the 4-meter walk test test-retest reliability and concurrent validity and its correlation with the five sit-to-stand test in chronic ambulatory stroke survivors. Gait & Posture, 2023; 101:8-13.
CESARI M, et al. Added value of physical performance measures in predicting adverse health-related events: results from the Health, Aging And Body Composition Study. J Am Geriatr Soc, 2009; 57: 251–9.
CRUZ-JENTOFT AJ, et al. Sarcopenia and severity of non-alcoholic fatty liver disease. Arquivo de Gastroenterologia, 2019; 56(4):357-360.
CRUZ-JENTOFT AJ, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age and Ageing, 2019; 48: 16–3.
FURLANETTO KC, et al. Reference Values for 7 Different Protocols of Simple Functional Tests: A Multicenter Study. Archives of Physical Medicine and Rehabilitation, 2022; 103(1):20-28.e5.
HE N, et al. Relationship Between Sarcopenia and Cardiovascular Diseases in the Elderly: An Overview. Front Cardiovasc Med. 2021; 8:743710.
KARPMAN C, et al. Measuring Gait Speed in the Out-Patient Clinic: Methodology and Feasibility. Respiratory Care, 2014; 59(4):531-7.
KELLER K e ENGELHARDT M. Strength and muscle mass loss with aging process. Age and strength loss. Muscles Ligaments Tendons J, 2014; 3(4): 346–350.
KO JB, et al. Predicting Sarcopenia of Female Elderly from Physical Activity Performance Measurement Using Machine Learning Classifiers. Clin Interv Aging, 2021; 16:1723-1733.
KRISTIANA T, et al. Association between Muscle Mass and Muscle Strength with Physical Performance in Elderly in Surabaya. Surabaya Physical Medicine and Rehabilitation Journal, 2020; 2(1), 24–34.
LANDI F, et al. Calf circumference, frailty and physical performance among older adults living in the community. Clin Nutr, 2014; 33: 539–44.
LEE HX, et al. Combined Impact of Positive Screen for Sarcopenia and Frailty on Physical Function, Cognition and Nutrition in the Community Dwelling Older Adult. Ann Geriatr Med Res, 2021; 25(3):210-216.
MAGGIO M, et al. Instrumental and Non-Instrumental Evaluation of 4-Meter Walking Speed in Older Individuals. PLoS ONE, 2016; 11(4):e0153583.
MALMSTROM T, et al. SARC-F: A symptom score to predict persons with sarcopenia at risk for poor functional outcomes. Journal of Cachexia, Sarcopenia and Muscle, 2016; 7(1):28-36.
MARTINEZ BP, et al. Massa e força muscular em idosos. Revista Brasileira de Geriatria e Gerontologia, 2016; 19(2):257-264.
MCLEAN RR e KIEL DP. Developing Consensus Criteria for Sarcopenia: An Update. Journal of Bone and Mineral Research, 2015; 30(4):588-92.
MELO TA de, et al. Teste de Sentar-Levantar Cinco Vezes: segurança e confiabilidade em pacientes idosos na alta da unidade de terapia intensiva. Rev Bras Ter Intensiva, 2019; 31(1):27-33.
NOLAN CM, et al. Gait speed and prognosis in patients with idiopathic pulmonary fibrosis: a prospective cohort study. European Respiratory Journal, 2019; 53: 1801186.
PARRA BFCS, et al. SARC-PRO Proposta de protocolo de sarcopenia em pacientes internados. BRASPEN J, 2019; 34 (1): 58-63
PETERS DM, et al. Assessing the reliability and validity of a shorter walk test compared with the 10-Meter Walk Test for measurements of gait speed in healthy, older adults. J Geriatr Phys Ther., 2013; 36(1):24-30.
PPINIJMUNG P, et al. Prevalence and Impact of Sarcopenia in Heart Failure: A Cross-Sectional Study. The Open Cardiovascular Medicine Journal, 2022; 16 (2202240) 1874-1924.
RIBEIRO HS, et al. Association between sarcopenia and clinical outcomes in chronic kidney disease patients: A systematic review and meta-analysis. Clinical Nutrition, 2022; 41 (5) 1131-1140.
RODRIGUES F, et al. A review on aging, sarcopenia, falls and resistance training in community-dwelling elderly. Int. J. Environ. Res. Public Health, 2022; 19(2): 874.
SANTOS KPC, et al. Avaliação nutricional de pacientes com doença hepática crônica: comparação entre diferentes métodos. BRASPEN J, 2018; 33 (2): 170-5.
SOUZA IP, et al. Utilização do SARC-F para triagem de sarcopenia em pacientes adultos hospitalizados, Ntr Clín Diet Hosp., 2020; 40(3): 99-105.
SPATZ ES, et al. Community factors and hospital wide readmission rates: Does context matter? PLoS ONE 1. 2020; 10(0240222).
VAN PUYENBROECK K, et al. The Additional Value of Bioelectrical Impedance Analysis-Derived Muscle Mass as a Screening Tool in Geriatric Assessment for Fall Prevention. Gerontology, 2012; 58(5):407-12.
WALLMANN HW, et al. Interrater reliability of the fivetimes-sit-to-stand test. Home Health Care Manag Pract. 2012; 25(1):13-17.
WAN M, et al. Cellular senescence in musculoskeletal homeostasis, diseases, and regeneration. Bone Res., 2021;9(1):41.
WELCH C, et al. Acute Sarcopenia Secondary to Hospitalisation - An Emerging Condition Affecting Older Adults. Aging Dis., 2018; 9(1):151-164.
ZHANG X, et al. Falls among older adults with sarcopenia dwelling in nursing home or communCOBOity: A meta-analysis. Clin Nutr., 2020; 39(1):33-39.